tirzepatide novo nordisk FDA confirms shortage is still over, gives compounders a grace period Novo Nordisk's CagriSema Shows Strong

Deeply understand physician and payer dynamics, and build strategy accordingly: Deeply understand physician and payer dynamics, and build strategy accordingly: Understanding the differences between primary care provider versus endocrinologist perceptions and prescribing behaviors (e.g., class preferences, route of administration preferences, etc.) is foundational to developing strategies that account for stakeholder-specific nuances

Some people mention Mounjaro in this context as well

In physiological conditions, the tubuloglomerular feedback (TGF) signaling can adjust a stable glomerular filtration rate (GFR) by modulation of preglomerular arteriole tone

It helps explain the scale by revealing how increases in muscle mass may influence slower weight loss

Reported or theoretically plausible side effects of CJC 1295 and ipamorelin include: Water retention and peripheral oedema Flushing, headache, and dizziness, particularly after injection Tingling or numbness in the extremities Elevated IGF-1 levels, which over time may theoretically increase the risk of certain cancers, though a direct causal link has not been established in clinical studies [13] [14] Impaired glucose tolerance or insulin resistance GH excess and GH secretagogues are more commonly associated with raised blood glucose rather than hypoglycaemia